“I established the task force in recognition that many of our health science faculty were individually already engaging in research, education and practice activities relevant to addressing the opioid epidemic,” said Carrie L. Byington, MD, dean of the Texas A&M College of Medicine, senior vice president of the Texas A&M University Health Science Center and vice chancellor for health services at The Texas A&M University System. “By working together, we can create an even greater impact in preventing and managing the devastating consequences faced by Texans and others around the country.”
The task force includes representatives from the five components of the center: dentistry, medicine, nursing, public health and pharmacy as well as the Coastal Bend Health Education Center. The task force will focus its efforts on research, education and practice issues associated with the opioid epidemic in Texas.
Two studies by task force members won funding for the first year of the 10-year, $100 million President’s Excellence Fund, T3: Texas A&M Triads for Transformation. These studies include the examination of the opioid epidemic’s impact on older adults and the development of a system for opiate withdrawal symptoms.
More articles on opioids:
Florida law puts 3-day limit on opioid prescriptions for acute pain
Trump: DOJ considering ‘major litigation’ against opioid companies
Medicaid essential to addressing opioid epidemic: 4 report insights
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
